@article{fa32c362958e42089c2ad6d690b592d0,
title = "The SYK inhibitor: a novel agent for improved outcomes in relapsed/refractory diffuse large B-cell lymphoma",
keywords = "SYK inhibitor, TAK-659, aggressive non-Hodgkin lymphoma, diffuse large B-cell lymphoma, mivavotinib",
author = "Reem Karmali and Frederique St-Pierre and Gordon, {Leo I.}",
note = "Funding Information: Financial & competing interests disclosure Reported trial funded by Takeda Pharmaceutical Company Limited. R Karmali - advisory board: BMS, Gilead Sciences/Kite Pharma, Janssen, Pharmacyclics, Morphosys, Genentech/Roche, Calithera, Miltenyi, Lilly Oncology; grants/research support: BMS, Takeda, BeiGene, Gilead Sciences/Kite, Calithera; speakers bureau: AstraZeneca, BeiGene, Morphosys. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending or royalties. Funding Information: Reported trial funded by Takeda Pharmaceutical Company Limited. R Karmali – advisory board: BMS, Gilead Sciences/Kite Pharma, Janssen, Pharmacyclics, Morphosys, Genentech/Roche, Calithera, Miltenyi, Lilly Oncology; grants/research support: BMS, Takeda, BeiGene, Gilead Sciences/Kite, Calithera; speakers bureau: AstraZeneca, BeiGene, Morphosys. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending or royalties. ",
year = "2023",
month = apr,
day = "1",
doi = "10.2217/fon-2022-1280",
language = "English (US)",
volume = "19",
pages = "737--738",
journal = "Future Oncology",
issn = "1479-6694",
publisher = "Taylor and Francis Ltd.",
number = "11",
}
